TY  - BOOK
ED  - United States.
TI  - Reviewing the rising price of EpiPens: hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fourteenth Congress, second session, September 21, 2016
AV  - KF27 .O94 2016
PY  - 2017///
CY  - Washington
PB  - U.S. Government Publishing Office
KW  - Mylan, Inc
KW  - Corrupt practices
KW  - Adrenaline
KW  - Prices
KW  - United States
KW  - Drug delivery devices
KW  - Legislative hearings
KW  - lcgft
N1  - Paper version available for sale by the Superintendent of Documents, U.S. Government Publishing Office; "Serial no. 114-124."; CRDP Program record; Includes bibliographical references
UR  - http://purl.fdlp.gov/GPO/gpo80186
ER  -